The global poultry diagnostics demand is subjected to record a CAGR of 10.5%. The market revenue is likely to be valued at US$ 590 million in 2023 and exhibit a revenue growth of US$ 1.6 billion by 2033.
Global Trends & Opportunities Revamping the Poultry Diagnostics Market
Key players concentrate on scientific and technical services for the food, agricultural, and veterinary industries. They specialize in serologic diagnostic services for the poultry business. They further broaden their reach by providing diagnostic services to enterprises that produce animals for human consumption. These industries include the bovine, porcine, shrimp, and tilapia sectors. In addition, they provide training and microbiological testing services to the food and agroindustry in general. They bring together the finest from sample preparation to identification, for infections, quality indicators, food fraud, and more, with proven solutions for every stage of the test workflow.
End users can select between manual and automated solutions that are designed to produce accurate results and maximize efficiency, thus boosting the demand. Key businesses additionally provide effective testing methodologies and cutting-edge technology for the current epidemics. End users may obtain recent lessons learned on addressing the present supply chain crisis from important thought leaders. Furthermore, companies can gain an efficient and cost-effective method of scaling up testing to meet the problems given by rapid outbreaks. Therefore, these developments are helping the market to prosper.
Veterinarians may reliably obtain full diagnostic insights anytime, anywhere, thanks to artificial intelligence (AI) algorithms that provide cost-effective access to expert-level results, remote veterinary specialist evaluation, and post-diagnostic consultations. The unique combination of goods and services given by key stakeholders provides a more comprehensive picture, allowing veterinarians to make faster, more educated medical decisions for more tailored treatment. Additionally, significant businesses concentrate their innovation on identifying and developing the integrated solutions that their veterinarian and livestock producer clients require in order to flourish, thus benefiting the market.
Their portfolio contributes to the spectrum of care for predicting, preventing, detecting, and treating disease in animals. They also provide a wide range of innovative testing solutions for veterinary laboratories and organizations. This is to battle influenza A in poultry in the midst of a significant outbreak, particularly in Europe and Asia Pacific. The emergence of the highly deadly H5N8 strain of avian influenza A has resulted in significant losses for the poultry sector, including the mortality of almost 12 million birds. The broad array of quick detection tools offered by key players includes the highly reliable, ready-to-use virotype Influenza A RT-PCR kit created by another important player which is a good sign for market growth.
Key participants desire to influence the future of poultry health via disease prevention, aiming to help win the struggle against poultry illnesses and shape the future of poultry well-being and correspondingly aid market growth. Their extensive portfolio of vaccinations and delivery devices provides unrivaled protection against a wide range of poultry health concerns. Among these are vaccinations against Marek's disease, infectious bursal disease, newcastle disease, and others. Key businesses provide existing and novel vaccines, diagnostics, research services, technological experience, and an unwavering commitment to their customer's success. As a result, they play an important role in providing safe, inexpensive, plentiful, and sustainable quality chicken meat and eggs to the world. This is providing impetus to the market for poultry diagnostics as a whole.
| Attributes | Details |
|---|---|
| Poultry Diagnostics Market HCAGR (2017 to 2022) | 12.2% |
| Poultry Diagnostics Market CAGR (2023 to 2033) | 10.5% |
| Market Size for Poultry Diagnostics (2023) | US$ 590 million |
| Market Size for Poultry Diagnostics (2033) | US$ 1.6 billion |
| Market Size for Poultry Diagnostics - Absolute Dollar Growth | US$ 1 billion |
The demand for foods high in protein has grown as people become more conscious of maintaining good health. In addition to having a high protein content, chicken products like eggs and meat also include iron, magnesium, zinc, vitamin B, and vitamin E. Therefore, it is anticipated that the market would rise in response to the rising need for productive poultry farming.
Starting this business requires between US$ 5,000 and US$ 25,000 in funding. The increased profitability of poultry farming is driving up demand for it in the market. The United States economy as a whole was US$ 35.5 billion larger in 2020 due to the production of chicken. Therefore, it is projected that improvements in science and technology, together with government backing in the form of programs like subsidies, is anticipated to spark innovations in the poultry diagnostics market trends.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Research from Future Market Insights claims that the global forum for poultry diagnostics has lately experienced phenomenal growth. The leading competitors on the market have joined forces to satisfy the expanding demand for poultry diagnostics. The CAGR, which was 12.2% from 2017 to 2022, is expected to decline to 10.5% during the forecasted period.
Poultry healthcare techniques include evacuating sick birds, administering immunizations on time, managing healthcare resources, and maintaining sanitation, feeding and feed supply, housing, and other aspects of poultry management.
Primary poultry wound care can be done by thoroughly washing the wound/infected area with water, hydrogen peroxide. Vetericyn Plus Poultry Care spray is commonly used by farmers as first care. Various poultry wound care products are easily available nowadays.
The global poultry diagnostics market is being driven by rising disease outbreaks such as newcastle disease and avian influenza, besides others, and also growing demand for chicken as a food due to rising interest in poultry farming in emerging and developed countries. Avian Influenza, Avian Mycoplasmosis, Avian Salmonellosis, and Infectious Bronchitis are a few diseases that affect birds.
Eggs are widely consumed worldwide and are an important ingredient for bakery products, consumption of food products made of infected eggs can lead to food poisoning. As a result, dairy diagnostics are necessary to avoid such situations. Efficient dairy diagnostics detects problems at the initial stage and avoids any unwanted illness.
One of the significant factors responsible for the growth of the poultry diagnostics market is the rise in disease spread in poultry around the world. The introduction of animal health information portals, particularly in developed economies, as well as increased initiatives taken by respective governments and animal welfare organizations, has accelerated market expansion.
By test type, the market is segmented into ELISA and PCR. Future Market Insights projects that the ELISA category is likely to have a sizable market share of 10.2% over the course of the projected period.
The enzyme-linked adsorption assay (ELISA) test is predicted to have a higher market share in 2023. The ELISA is the most extensively used test to detect or diagnose virus infection, particularly infection of blood-borne viruses. Its sensitivity and practicality have made it the most used first screening assay. ELISA tests are also frequently used to identify antibodies in the blood.
Infectious such as avian influenza, which is widespread in developed countries, are easily detected with ELISA. ELISA is a highly dependable and cost-effective method. This feature has increased ELISA's acceptance around the world. Diluents and buffers, which are employed in ELISA, are also less expensive than other diagnostic choices, which help to increase diagnostics demand.
According to analysts at Future Market Insights, the avian influenza category is expected to have a sizeable market share of 9.8% over the forecast period.
Avian influenza is expected to dominate the poultry diagnostics industry. The most common pathogenic kind that infects domestic birds is avian influenza. Bird flu is another name for avian influenza. Avian influenza (AI) is a highly contagious viral infection that affects a variety of food-producing birds.
Avian influenza has been linked to respiratory illnesses, reduced egg production, and subclinical infections. A high pathogenic (HPAI) version of the virus has been reported to harm domestic flocks in a few cases. Systemic diseases and death are caused by increased pathogenic type.
Avian salmonellosis, on the other hand, is the one of the infection that causes chicken disease. Pullorum fever, paratyphoid, and poultry typhoid are all caused by Salmonella. As a result, the demand for poultry diagnostic labs grows.
Principal Consultant
Uncertainty over poultry management is anticipated to be a problem in developing nations like India and China. Lack of quick poultry test kits and a shortage of specialists in emerging markets are likely to act as restraints for the poultry diagnostics market growth.
On the contrary, both veterinary hospitals and clinics receiving government funding as well as the demand for food items generated from poultry have increased. During the projected period, these factors are likely to drive the worldwide market for poultry diagnostics.
| Country | United States |
|---|---|
| CAGR (2023 to 2033) | 10.3% |
| HCAGR (2017 to 2022) | 14.5% |
| Country | United Kingdom |
|---|---|
| CAGR (2023 to 2033) | 9.5% |
| HCAGR (2017 to 2022) | 13.5% |
| Country | China |
|---|---|
| CAGR (2023 to 2033) | 9.9% |
| HCAGR (2017 to 2022) | 14.1% |
| Country | Japan |
|---|---|
| CAGR (2023 to 2033) | 9% |
| HCAGR (2017 to 2022) | 12.9% |
| Country | South Korea |
|---|---|
| CAGR (2023 to 2033) | 8.2% |
| HCAGR (2017 to 2022) | 11.5% |
| Attributes | Details |
|---|---|
| United States Market Size (2033) | US$ 566.9 million |
| United States Market Absolute Dollar Growth (US$ million/billion) | US$ 353.7 million |
The United States is the market leader in poultry diagnostics, accounting for 10.3% of total North America sales. The poultry diagnostics market in the United States is expected to reach a high of US$ 566.9 million. Various portals that supply animal health information are one reason driving market expansion. Farmers may use these portals to keep track of preventative diagnostics, missed immunizations, nutritional information, and essential diagnostic tests.
Key players in the United States urge end user to collaborate with them for precise poultry testing that is expected to create trust in them. Their cutting-edge solutions eliminate the need for extensive testing. Furthermore, they provide tested solutions that encourage decisive action. Poultry testing laboratories in the United States seek to safeguard and promote poultry health.
The Board of Animal Health is the state regulatory agency in charge of keeping farmers and industry up to date on many ongoing disease surveillance programs, as well as responding to and acting as necessary. Universities offer the necessary space, hands-on technical experience, and laboratory professionals to support poultry disease surveillance and diagnosis programs.
In the United States, molecular methods such as PCR and sequencing are encouraged. They give the most up-to-date information on a flock's health and are commonly utilized in human and veterinary diagnostics. Key players use cutting-edge products and systems to monitor and optimize poultry health. Furthermore, prior to batch release, all of their assays are subjected to stringent validation processes. Furthermore, they provide 'software store' results as well as flock/herd information in an online database. This enables users to effectively manage poultry diagnostics.
| Attributes | Details |
|---|---|
| United Kingdom Market Size (2033) | US$ 67.3 million |
| United Kingdom Market Absolute Dollar Growth (US$ million/billion) | US$ 40.3 million |
The United Kingdom is a substantial poultry diagnostics market, with an estimated value of US$ 67.3 million and a revenue growth rate of 9.5% during the forecast period. The rise in zoonotic illnesses is a significant factor driving market expansion. Furthermore, significant businesses provide poultry diagnostic kits that yield high-quality, dependable findings. This allows for the low-cost identification of a wide range of diseases such as IBD, IBV, NDV, and AIV.
Researchers developed numerous methods and procedures to assess the breadth of immune responses elicited by vaccinations against several forms of the infectious bursal disease virus (IBDV). Vaccination is the primary technique of disease prevention in poultry. However, diverse strains of IBDV are spreading around the world. As a result, key players are motivated to establish if vaccination against one strain might elicit an immune response against other viral types. Ultimately, they want to know how many distinct versions a vaccination can protect against.
Many sections of the poultry business benefit from key companies' veterinary consulting and diagnostic services. They are essentially poultry doctors who provide a comprehensive variety of veterinary services such as quick access telephone counselling, rapid post-mortem examination, disease control health planning, and so on. Furthermore, they provide extensive online training in a variety of therapeutic areas to assist veterinary doctors in managing illnesses and using goods as safely and efficiently as possible.
| Attributes | Details |
|---|---|
| China Market Size (2033) | US$ 114.8 million |
| China Market Absolute Dollar Growth (US$ million/billion) | US$ 70 million |
China is a lucrative poultry diagnostics market, with a revenue growth rate of 9.9% and a forecasted value of US$ 114.8 million during the forecast year. Increased government and animal welfare operations in the country to raise awareness about poultry illnesses are also helping to expand the industry. Moreover, rising zoonotic disease prevalence and increasing avian diseases are expected to drive market growth throughout the forecast period.
The massive expansion in chicken production to serve China's expanding demand has resulted in an increase in antibiotic usage. This resulted in an alarming cases of antibiotic resistance (ABR) detected in animals and, as a result, people, through direct contact, environmental pollution, and food intake. Therefore, machine learning is expected to be used by key stakeholders to uncover new techniques to identify and target sickness in Chinese poultry farms. This lessens the requirement for antibiotic therapy while also lowering the likelihood of antibiotic resistance spreading to human populations.
New diagnostics are predicted to provide huge benefits to broiler farmers and may represent the key to more successful bird management. Key participants argue that poultry serum tests and causer tests, in addition to periodic monitoring and data collection management, are required to diagnose poultry illnesses. Their poultry test devices work well in terms of complete chicken serum profile management. It also has high dependability and data compatibility.
| Attributes | Details |
|---|---|
| Japan Market Size (2033) | US$ 93.8 million |
| Japan Market Absolute Dollar Growth (US$ million/billion) | US$ 54.1 million |
Japan is an important poultry diagnostics market, representing 9% of overall sales. The Japanese poultry diagnostics market is estimated to be worth US$ 93.8 million. In order to enhance poultry health in Japan, leading physicians use new technology to offer diagnostic services. In response to requests from Japan's central and municipal governments, they may detect unusual ailments, including exotic diseases.
In Japan, key businesses manufacture diagnostic agents, vaccinations, and other medications that are essential for the protection of agricultural stock against infectious illnesses. Furthermore, they principally offer these biologicals to organizations in charge of disease prevention and control, as well as animal quarantine throughout the nation. In addition, they examine illness circumstances, distribution patterns, and economic damages using epidemiological methodologies. Their study is to identify risk factors for disease outbreaks and to develop effective control and prevention methods.
Since the 20th century, several farms in Japan has declined while the poultry population has expanded. This indicates that farms have gotten more technologically advanced and have chosen intense and efficient production methods. Furthermore, effective poultry practices have produced seasonal and national consumption-based poultry productivity intervals. This has resulted in a rise in demand for poultry diagnostics in the country, resulting in varied market opportunities.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Start-up companies are introducing advanced technologies and services to contribute to the global poultry diagnostics market growth:
The poultry diagnostics market is very competitive due to the existence of several established rivals. In order to capitalize on market growth potential, these companies are concentrating on expanding their reach through acquisitions, expansions, product approvals, and launches.
Recent Developments:
The Poultry Diagnostics Market is pegged at a value of US$ 590 million in 2023.
The Poultry Diagnostics Market is estimated to reach US$ 1.6 billion by 2033.
Sales of fine hydrates are anticipated to surge at a noteworthy CAGR of 10.5% through 2033.
The market for poultry diagnostics is thriving in China thanks to the country's large poultry population, rising meat consumption, and government support.
In 2022, the Poultry Diagnostics Market reached a value CAGR of 12.2%.
1. Executive Summary | Poultry Diagnostics Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Analysis 2017 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Test 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Test, 2017 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Test, 2023 to 2033 5.3.1. ELISA Test 5.3.2. PCR Test 5.4. Y-o-Y Growth Trend Analysis By Test, 2017 to 2022 5.5. Absolute $ Opportunity Analysis By Test, 2023 to 2033 6. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Disease 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Disease, 2017 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Disease, 2023 to 2033 6.3.1. Avian Salmonellosis 6.3.2. Avian Influenza 6.3.3. Newcastle Disease 6.3.4. Avian Mycoplasmosis 6.3.5. Avian Pasteurellosis 6.3.6. Infectious Bronchitis 6.3.7. Infectious Bursal Disease 6.3.8. Avian Encephalomyelitis 6.3.9. Avian Reovirus 6.3.10. Chicken Anemia 6.4. Y-o-Y Growth Trend Analysis By Disease, 2017 to 2022 6.5. Absolute $ Opportunity Analysis By Disease, 2023 to 2033 7. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Service 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Service , 2017 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Service , 2023 to 2033 7.3.1. Bacteriology 7.3.2. Virology 7.3.3. Parasitology 7.4. Y-o-Y Growth Trend Analysis By Service , 2017 to 2022 7.5. Absolute $ Opportunity Analysis By Service , 2023 to 2033 8. Global Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. East Asia 8.3.5. South Asia 8.3.6. Oceania 8.3.7. Middle East and Africa 8.4. Market Attractiveness Analysis By Region 9. North America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Test 9.2.3. By Disease 9.2.4. By Service 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Test 9.3.3. By Disease 9.3.4. By Service 9.4. Key Takeaways 10. Latin America Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Argentina 10.2.1.4. Rest of Latin America 10.2.2. By Test 10.2.3. By Disease 10.2.4. By Service 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Test 10.3.3. By Disease 10.3.4. By Service 10.4. Key Takeaways 11. Europe Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. Italy 11.2.1.3. France 11.2.1.4. United kingdom 11.2.1.5. Spain 11.2.1.6. BENELUX 11.2.1.7. Russia 11.2.1.8. Rest of Europe 11.2.2. By Test 11.2.3. By Disease 11.2.4. By Service 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Test 11.3.3. By Disease 11.3.4. By Service 11.4. Key Takeaways 12. East Asia Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. China 12.2.1.2. Japan 12.2.1.3. South Korea 12.2.2. By Test 12.2.3. By Disease 12.2.4. By Service 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Test 12.3.3. By Disease 12.3.4. By Service 12.4. Key Takeaways 13. South Asia Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. India 13.2.1.2. Thailand 13.2.1.3. Indonesia 13.2.1.4. Malaysia 13.2.1.5. Rest of South Asia 13.2.2. By Test 13.2.3. By Disease 13.2.4. By Service 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Test 13.3.3. By Disease 13.3.4. By Service 13.4. Key Takeaways 14. Oceania Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Test 14.2.3. By Disease 14.2.4. By Service 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Test 14.3.3. By Disease 14.3.4. By Service 14.4. Key Takeaways 15. Middle East and Africa Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. Türkiye 15.2.1.3. South Africa 15.2.1.4. Rest of Middle East and Africa 15.2.2. By Test 15.2.3. By Disease 15.2.4. By Service 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Test 15.3.3. By Disease 15.3.4. By Service 15.4. Key Takeaways 16. Key Countries Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Test 16.1.2.2. By Disease 16.1.2.3. By Service 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Test 16.2.2.2. By Disease 16.2.2.3. By Service 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Test 16.3.2.2. By Disease 16.3.2.3. By Service 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Test 16.4.2.2. By Disease 16.4.2.3. By Service 16.5. Argentina 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Test 16.5.2.2. By Disease 16.5.2.3. By Service 16.6. Germany 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Test 16.6.2.2. By Disease 16.6.2.3. By Service 16.7. Italy 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Test 16.7.2.2. By Disease 16.7.2.3. By Service 16.8. France 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Test 16.8.2.2. By Disease 16.8.2.3. By Service 16.9. United kingdom 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Test 16.9.2.2. By Disease 16.9.2.3. By Service 16.10. Spain 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Test 16.10.2.2. By Disease 16.10.2.3. By Service 16.11. BENELUX 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Test 16.11.2.2. By Disease 16.11.2.3. By Service 16.12. Russia 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Test 16.12.2.2. By Disease 16.12.2.3. By Service 16.13. China 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Test 16.13.2.2. By Disease 16.13.2.3. By Service 16.14. Japan 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Test 16.14.2.2. By Disease 16.14.2.3. By Service 16.15. South Korea 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Test 16.15.2.2. By Disease 16.15.2.3. By Service 16.16. India 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Test 16.16.2.2. By Disease 16.16.2.3. By Service 16.17. Thailand 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Test 16.17.2.2. By Disease 16.17.2.3. By Service 16.18. Indonesia 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Test 16.18.2.2. By Disease 16.18.2.3. By Service 16.19. Malaysia 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Test 16.19.2.2. By Disease 16.19.2.3. By Service 16.20. Australia 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Test 16.20.2.2. By Disease 16.20.2.3. By Service 16.21. New Zealand 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Test 16.21.2.2. By Disease 16.21.2.3. By Service 16.22. GCC Countries 16.22.1. Pricing Analysis 16.22.2. Market Share Analysis, 2022 16.22.2.1. By Test 16.22.2.2. By Disease 16.22.2.3. By Service 16.23. Türkiye 16.23.1. Pricing Analysis 16.23.2. Market Share Analysis, 2022 16.23.2.1. By Test 16.23.2.2. By Disease 16.23.2.3. By Service 16.24. South Africa 16.24.1. Pricing Analysis 16.24.2. Market Share Analysis, 2022 16.24.2.1. By Test 16.24.2.2. By Disease 16.24.2.3. By Service 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Test 17.3.3. By Disease 17.3.4. By Service 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Agrobiotek Internacional 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Affinitech Ltd. 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Biochek 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Bioingentech Biotechnologies Inc. 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. Bionote Inc. 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Boehringer Ingelheim GmbH 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. GD Animal Health 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Idexx Laboratories Inc. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. IDVet 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. Megacor Diagnostik GmbH 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 18.1.11. Qiagen N.V. 18.1.11.1. Overview 18.1.11.2. Product Portfolio 18.1.11.3. Profitability by Market Segments 18.1.11.4. Sales Footprint 18.1.11.5. Strategy Overview 18.1.11.5.1. Marketing Strategy 18.1.12. Thermo Fisher Scientific 18.1.12.1. Overview 18.1.12.2. Product Portfolio 18.1.12.3. Profitability by Market Segments 18.1.12.4. Sales Footprint 18.1.12.5. Strategy Overview 18.1.12.5.1. Marketing Strategy 18.1.13. Zoetis Inc. 18.1.13.1. Overview 18.1.13.2. Product Portfolio 18.1.13.3. Profitability by Market Segments 18.1.13.4. Sales Footprint 18.1.13.5. Strategy Overview 18.1.13.5.1. Marketing Strategy 18.1.14. Bioneer Corporation 18.1.14.1. Overview 18.1.14.2. Product Portfolio 18.1.14.3. Profitability by Market Segments 18.1.14.4. Sales Footprint 18.1.14.5. Strategy Overview 18.1.14.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Explore Healthcare Insights
View Reports
Poultry Diagnostics Market
